Evidence map›Paper›PMID 34934306›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2021

A One Year Longitudinal Comparative Analysis of Visual Outcomes Between Femtosecond Laser-Assisted Cataract Surgery and Standard Phacoemulsification Cataract Surgery.

Majid Moshirfar, Austin J Waite, James H Ellis, Rachel Huynh, John Placide, Matthew R Barke, Shannon E McCabe, Yasmyne C Ronquillo, Phillip C Hoopes, Michael J Bradley and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Plants (Basel, Switzerland) · 2026
    Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Majid MoshirfarHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0003-1024-6250
Austin J WaiteA.T. Still University College of Osteopathic Medicine in Arizona, Mesa, AZ, USA.ORCID 0000-0002-8043-5893
James H EllisUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
Rachel HuynhUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
John PlacideMcGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA.
Matthew R BarkeMcGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA.ORCID 0000-0002-6759-8743
Shannon E McCabeHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0002-6339-3628
Yasmyne C RonquilloHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0002-8852-4380
Phillip C HoopesHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.
Michael J BradleyHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.
Phillip C HoopesHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0002-2567-8331
Hoopes Vision · USUniversity of Utah · USThe University of Texas Health Science Center at Houston · USA.T. Still University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess visual outcomes over time of femtosecond laser-assisted cataract surgery compared to standard phacoemulsification cataract surgery.

designA retrospective, single-center comparative study.

methodsPatient data including demographics, ocular biometry, pre- and postoperative visual acuity, postoperative complications, primary (uncorrected distance visual acuity over time) and secondary visual outcomes (uncorrected near visual acuity, best distance visual acuity, patient complaints, satisfaction, and postoperative surgery) were gathered and statistically analyzed. Demographic differences between patients receiving femtosecond-laser assisted cataract surgery (FLACS) versus standard phacoemulsification cataract surgery (PCS) were corrected for outcome comparison. Safety, efficacy, predictability, and stability were analyzed for each procedure and compared.

resultsA total of 155 eyes in PCS and 143 eyes in FLACS were analyzed at 1 week, 3 months, and 1 year using odds ratio. The odds ratio of being 20/20 or better and 20/40 or better at the specified time periods were similar and statistically insignificant at all time periods analyzed except 20/20 or better for uncorrected distance visual acuity (UDVA) at 1 year (p=0.0001) and uncorrected near visual acuity (UNVA) at 1 week (p=0.02). In both cases, the odds of being 20/20 or better favored FLACS. Mean UDVA, UNVA, and best distance visual acuity (BDVA) were all similar and statistically insignificant between the two groups. Postoperative patient complaints, safety, efficacy, predictability, and stability between the two groups showed no statistical significance.

conclusionDespite the odds ratio of being 20/20 or better favoring FLACS for UDVA at 1 year and UNVA at 1 week, the mean logMAR UDVA, BDVA, and UNVA were similar and statistically insignificant between the FLACS and PCS groups at 1 week, 3 months, and 1 year. Differences in visual acuity were likely due to differences other than surgical approaches. While both FLACS and PCS are appropriate approaches to cataract surgery, one does not appear to be superior when assessing longitudinal markers for visual acuity, safety, efficacy, predictability and stability.

Indexed as

best distance visual acuitycataractscataract surgeryfemtosecond-laser assisted cataract surgeryphacoemulsification cataract surgeryuncorrected distance visual acuityuncorrected near visual acuity

Identifiers

PMID34934306
PMCPMC8684426
OpenAlexW4200154895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.